Dashboard
With HIgh Debt (Debt-Equity Ratio at 21.32 times)- the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 10.91% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.05
Flat results in Jun 26
Stock is technically in a Bearish range
Risky - Negative EBITDA
Stock DNA
Diversified Commercial Services
INR 24 Cr (Micro Cap)
NA (Loss Making)
19
0.00%
21.32
-4,146.00%
24.20
Total Returns (Price + Dividend) 
Johnson Pharma for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Johnson Pharmacare Ltd Falls to 52-Week Low of Rs 0.36 as Sell-Off Deepens
A sharp decline has pushed Johnson Pharmacare Ltd to a fresh 52-week low of Rs 0.36 on 29 Oct 2026, marking a 41.54% drop over the past year and signalling intensified selling pressure despite a broadly stable market backdrop.
Read More
Markets Rally, But Johnson Pharmacare Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
Despite a broadly positive market environment, Johnson Pharmacare Ltd has plunged to a fresh 52-week low of Rs 0.39 on 15 Oct 2026, marking a steep decline of 34.92% over the past year and underperforming the Sensex by nearly 24 percentage points.
Read More
Markets Rally, But Johnson Pharmacare Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
Despite broader market attempts at recovery, Johnson Pharmacare Ltd has plunged to a fresh 52-week low of Rs 0.42 on 29 Sep 2026, marking a steep 45.45% decline over the past year and underscoring persistent headwinds for the micro-cap stock.
Read More Announcements 
Closure of Trading Window
26-Sep-2026 | Source : BSEPursuant to PIT (Regulation) 2015 the Trading window shall remain closed from 01st October 2026 till 48 hours after the declaration of unaudited financial result for the quarter and Half -Year ended 30th September 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Aug-2026 | Source : BSEPursuant to regulation 47 of LODR 2015 -Submission of extract of Newspaper Publication for the unaudited financial result for the quarter ended 30th June 2026.
Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th 2026 And Along With Limited Review Report Thereon.
13-Aug-2026 | Source : BSESubmission of Un-Audited Financial Results for the Quarter ended on June 30th 2026 and along with Limited Review Report Thereon.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Johnson Pharmacare Ltd has announced 1:10 stock split, ex-date: 05 Jan 22
Johnson Pharmacare Ltd has announced 1:10 bonus issue, ex-date: 07 Apr 22
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
None
Jagkarta Agencies Private Limited (2.78%)
85.56%
Quarterly Results Snapshot (Standalone) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Jun 2026 is -2,100.00% vs -25.00% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -50.00% vs 78.95% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -71.43% vs 63.16% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
YoY Growth in year ended Mar 2026 is -9,508.62% vs -190.00% in Mar 2025